20
Participants
Start Date
August 25, 2020
Primary Completion Date
October 7, 2022
Study Completion Date
October 7, 2022
SYNB1618
15-day dose-ramp regimen (4 dose levels) of orally administered SYNB1618
SYNB1934
15-day dose-ramp regimen (4 dose levels) of orally administered SYNB1934
Icahn School of Medicine at Mount Sinai, New York
University of Pittsburgh Medical Center, Pittsburgh
University of Florida College of Medicine, Gainesville
Excel Medical Clinical Trials, LLC, Boca Raton
Vanderbilt University Medical Center, Nashville
Washington University in St Louis, St Louis
University of Texas Health Science Center at Houston, Houston
Children's Hospital Colorado, Aurora
PRA Health Sciences, Salt Lake City
University Hospital Adult Services, Salt Lake City
Oregon Health and Science University, Portland
Lead Sponsor
Synlogic
INDUSTRY